Abstract
Aim: Valproic acid is an anticonvulsant and mood stabilizer used in various psychiatric and neurological conditions with a wide therapeutic window. This case report aims to emphasize that taking a drug in patients receiving psychiatric treatment can be toxic even if it is not at a toxic level. Case: A 33-year-old male patient was brought to the emergency room with complaints of decreased speech, slow movements, unresponsiveness, and blank stare for several days. According to the anamnesis taken from his father, it was learned that he had a known bipolar disorder and that his current complaints had increased for 2-3 days. Vital values were stable. The patient's laboratory and radiological examinations were within normal limits. When it was learned that valproic acid treatment had just started, drug level and ammonia level tests were requested considering the possibility of side effects. A diagnosis of hyperammonemia-induced encephalopathy was made due to high ammonia levels. Conclusion: While the treatment for valproic acid side effects is to discontinue the drug and follow up, in our patient, simply discontinuing the drug was not enough and he required hemodialysis treatment. With this case, we wanted to remind that hemodialysis can also be used in VPA-induced encephalopathy.

This publication has 8 references indexed in Scilit: